Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Which IoT-Enabled Features Should You Include In Your New Product Plans? February 13, 2018 Starter Guide to Six Axis Force and Torque Sensors March 8, 2018 Post-Game: 3D Printing News from Formnext 2019 November 25, 2019